FilingsTodayMegaMD
At a glance
MegaMD filed 17 disclosures in the last 12 months.
Revenue for 2025 was ₩34.6B, down 5.2% on 2024. Operating margin was 5.2% against 6.1% a year earlier. Debt was 25% of equity at year end.
The 2025 annual report lists 155 employees with an average tenure of 4.4 years and average pay of ₩42.3M, #1710 of 1,829 listed companies by average pay. Its 6 directors and auditors were paid ₩32M each on average. It paid ₩60 per common share in cash dividends, against ₩60 a year earlier (+0%). 메가스터디(주) and related parties held 43.53% at year end.
From the 2025 annual report
Staff: 155 (74 men, 81 women), of whom 8 on fixed-term contracts. Total pay for the year: ₩6.6B. Directors and auditors: 6, paid ₩193M in total.
Dividends (common shares)
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash dividend per share | ₩60 | ₩60 | - |
| Payout ratio | - | 35% | - |
| Yield (as filed) | 3.30% | 2.90% | - |
| Total cash dividends | ₩1.3B | ₩1.3B | - |
Largest shareholder
메가스터디(주) holds 43.15%; with 3 related parties the group holds 43.53% of common shares at year end.
Auditor: 한영회계법인 · opinion: Unqualified.
Source: 2025 annual business report (DART). How figures are combined
Financial summary
Key filings
No key filings in the last 12 months.
Other filings
Links open the original filing on DART, in Korean.